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Molecular genetic epidemiology 
of bipolar manic depressive illness 
and schizophrenia
eginning with the advent of DNA markers in
1978,and whole-genome genetic linkage marker maps in
the late 1980s, research into the genetic epidemiology
of bipolar manic depressive illness (BP) and schizo-
phrenia (SZ) has been aimed at identifying gene variants
that contribute to susceptibility to illness.This enterprise
has not yet seen success, but there are reasons for opti-
mism.Identification of susceptibility genes for complex
inheritance psychiatric disorders has recently become
feasible,due to advances in genomics and the analysis of
complex inheritance disorders.
Research strategies
Several alternative strategies for disease gene identifi-
cation may reasonably be considered at this time in the
development of genomics and the neuroscience of psy-
chiatric disorders:
• Study of candidate genes based on neurobiology.
• Comparative analysis of gene expression in ill and well
persons, followed by study of genes with differential
expression in ill persons.
Considerable advances have been made in identifying specific
genetic components of bipolar manic depressive illness (BP)
and schizophrenia (SZ), despite their complex inheritance.
Meta-analysis of all published whole-genome linkage scans
reveals overall support for illness genes in several chromosomal
regions. In two of these regions, on the long arm of chromo-
some 13 and on the long arm of chromosome 22, the com-
bined studies of BP and SZ are consistent with a common sus-
ceptibility locus for the two disorders. This lends some
plausibility to the hypothesis of some shared genetic predis-
positions for BP and SZ. Other linkages are supported by mul-
tiple studies of specific chromosomal regions, most notably
two regions on chromosome 6 in SZ. The velocardiofacial syn-
drome is associated with deletions very close to the linkage
region on chromosome 22, and with psychiatric manifesta-
tions of both BP and SZ. Endophenotypes of SZ, previously
demonstrated to be heritable, have been found to have chro-
mosomal linkage in at least one study. These include eye-track-
ing abnormalities linked to the short arm of chromosome 6,
and abnormality of the P50 cortical evoked potential linked to
chromosome 15. Variants in specific genes have been associ-
ated with susceptibility to illness, and other genes have been
associated with susceptibility to side effects of pharmacologi-
cal treatment. These genetic findings may eventually be part
of an integrated genetic, environmental, and interactive-factor
epidemiology of the major mental illnesses.
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- whole-genome association (linkage disequilibrium)
with densely spaced markers and/or/followed by
mutational analysis;
- positional cloning (detection of linkage,followed by
association and mutational analysis of genes within
the linkage region).
Positional approaches based on linkage are currently in
some disfavor, yet the recent success in type 2 diabetes
(see below),a common disease with similar inheritance
to psychiatric disorders,belies the current disfavor.This
review selectively focuses on a positional strategy,
because such strategies exhaust all possibilities and thus
have the capacity to uncover susceptibility genes that
are surprises (ie,for which there is no prior hypothesis).
Linkage followed by association (as opposed to genome-
wide association) is currently a feasible positional strate-
gic choice. This is not to suggest that other strategies
might not, in the end, prove more successful in finding
susceptibility mutations. The scientific advances sup-
porting the positional strategy include the following.
Completion of the finished sequence phase of the
Human Genome Project
The Human Genome Project has made enormous con-
tributions to the various maps of the human genome,
including genome-wide physical maps,very dense poly-
morphism maps, and integrated transcript maps. Suffi-
cient single nucleotide polymorphisms (SNPs) for very
dense mapping at almost all locations in the genome
have also been developed. The genome project is now
rapidly nearing its complete annotated sequence goal.
This enables the genomic sequence of any gene to be
examined in blood or other specimens from any indi-
vidual.An ability to do mutational analysis of any gene
or group of genes is a vast advance over what has been
so often done in psychiatry until now—testing one or a
few polymorphisms of a gene, and generalizing from
that result.
Recent scientific developments supporting the feasibility
of cloning genes for complex disorders,based on initial
linkage findings
The discovery of susceptibility genes for the major psy-
chiatric disorders,BP and SZ,is thought to include some
of the most intractable current problems in human genet-
ics.
1 The outlook for major advances based on genetic
linkage and linkage disequilibrium has now greatly
improved.The very recent availability of very dense SNP
and other polymorphism maps has greatly improved the
statistical power to detect linkage disequilibrium.Statis-
tical methods developed in recent years for linkage and
for combined linkage and linkage disequilibrium analy-
ses,including haplotype-based analyses,
2-6 are capable of
teasing apart subtle genetic components contributing to
common diseases with complex inheritance.
Detection of NIDDM1,a susceptibility gene for type 2
diabetes mellitus
An instructive recent report of a near-certain causal con-
nection between calpain 10 mutations and increased sus-
ceptibility to type 2 (non–insulin-dependent) diabetes
mellitus
7 demonstrates the plausibility of applying cur-
rently available experimental, statistical, and computa-
tional tools to the successful identification of complex
disease genes,starting with a linkage result.This discov-
ery was made despite the usual complications of com-
plex disease genetics: apparently inconsistent linkage
results;study of an outbred population;and no obvious
candidate genes in the linkage region. The keys to the
discovery were innovative and meticulous analysis of
disequilibrium in a sample of families with a positive
linkage result, and thorough molecular scrutiny of the
disequilibrium region.
Horikawa et al
7 found a strong statistical association of
type 2 diabetes with a complex haplotype that produces
an intronic polymorphism in the calpain 10 gene. The
haplotype was found by detection of a small region 
(66 kb) that showed disequilibrium, followed by inten-
sive examination of that region.The haplotype success-
fully partitioned the linkage evidence (it was associated
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Selected abbreviations and acronyms
BP bipolar manic depressive illness 
COMT catechol-O-methyltransferase 
MSP multiple scan probability
SNP single nucleotide polymorphism
SZ schizophrenia
TNR trinucleotide repeat
VCFS velocardiofacial syndrome65
with nearly all the linkage evidence in the sample in
which linkage was originally detected). In addition, the
haplotype was associated with increased relative risk of
illness in a Finnish population, and was found to alter
expression of the calpain 10 gene.
The sample studied by Horikawa et al is the only one
known with significant linkage evidence for type 2 dia-
betes in this region of chromosome 2.
8 It is a sample from
an outbred Mexican-American population, and one of
four samples studied in that report.There exist two other
major linkage reports: a report from a French sample,
which does not reach significance, but provides modest
nominal support for linkage (P values roughly 0.01 to
0.07), and a large multinational study, which is not at all
positive.
9,10 Meta-analysis of all reports using Fisher’s meta-
analysis test
11 gives a P value for the linkage of 5.6× 10
-5,
which retrospectively supports the approach taken by the
type 2 diabetes researchers (data not shown).
Calpain 10 had been a very unlikely candidate diabetes
gene, judging from its putative function and expression
pattern. The identification of calpain 10 relied exclu-
sively on positional data (derived from linkage and link-
age disequilibrium).This precedent underscores the util-
ity of a “no-a-priori-assumption” approach to complex
disease gene identification.Nonetheless,this approach is
especially powerful,and perhaps even necessary,for the
genetic dissection of complex diseases such as BP or SZ,
for which little mechanistic knowledge is available to
warrant educated guesses about their molecular etiology.
Recent history and interpretation of linkage 
results in psychiatry and results of meta-analysis 
of all published genome scans
Following analysis by Risch in 1990,
12 it became apparent
in SZ—and by implication in BP illness as well—that
the observed genetic epidemiological prevalences of
high concordance in monozygotic twins,and very much
lower relative risks in more distant relatives,implied oli-
gogenic inheritance. This, in turn, would require that
models of analysis be employed which are cognizant of
oligogenic inheritance. It also implies that linkage may
be detectable at multiple locations, without the results
contradicting each other.
The “modern” era of gene scans can be said to begin
with the development of a reasonably dense genomic
map of more informative linkage markers and efficient
multilocus analyses.In recent years,observations of link-
age have been reported to be consistent with small-
effects genes, using nonparametric analyses, or para-
metric analyses with suitable parameters to “cover”oli-
gogenic inheritance (analysis under both a dominant
and a recessive model, allowance for phenocopies, and
low penetrance).
13-16 There have been only intermittent
replications of these observations,as summarized in pub-
lished reviews,
17-19 but there is not a complete absence
of credible replication,as was true earlier.
It is possible to intuitively reject data out of hand when
not all studies are positive, but it has long been recog-
nized that it is desirable to develop a systematic meta-
analytic statistical approach to the total linkage data for
a given disease. Fisher’s method of meta-analysis
involves taking the P values from individual studies and
testing the null hypothesis that these P values fit a uni-
form distribution.
20 This method has been applied to
linkage studies by using the same P values at the same
point in the genome from each linkage study.
21 This
information,however,is frequently not available in pub-
lished studies, but information is generally available
about the local minimum P value and its associated
genome location. Allison and Heo,
11 and Badner and
Gershon (unpublished data) applied Fisher’s meta-
analysis method to analyze common disease results.
Badner and Gershon used a method of statistical analy-
sis based on the P values observed in a chromosomal
region, using the mathematical formula of Feingold.
22
This allows for the inherent variability of the observed
peak, and for the use of different markers in different
studies. The minimum P values and their locations
reported in the several studies are “corrected” for the
distance away from the location of the peak of the most
significant study. (The corrected P value of a study is
higher, and thus less significant, if its peak is at a dis-
tance from the most significant peak.) The test of Fisher
is then applied.The significance of the Fisher statistic is
termed the multiple scan probability (MSP).Badner and
Gershon
23 performed simulations and determined that a
genome-wide significance criterion is appropriate for
this statistic (such as the affected-sib-pair criterion where
2.2× 10
-5 is significant and 7× 10
-4 is suggestive
24). Passing
the threshold is interpreted to mean that a significant
deviation from the null hypothesis of no linkage is pre-
sent in at least some of the data.
As with any method of meta-analysis, our analysis
would be susceptible to publication biases, ie, linkage
results being more likely to be published if they are
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positive. However, this bias is much less likely if only
the results of whole-genome scans are included in our
analysis of psychiatric disorders. This is because
whole-genome scans are likely not to remain unpub-
lished, even if they lack a significant linkage. In omit-
ting published evidence that are not from whole-
genome scans, we are mindful that some true findings
might be omitted from our analysis, such as the link-
ages to SZ reported separately on each arm of chro-
mosome 6.
25-29
Our simulations (not shown) indicate that results
from different analytical methods can be combined
so long as a particular result is not included on the
basis of its significance. For the current study, we
developed an objective hierarchy for choosing affec-
tion status model and analytical method, so that
results of each scan were not preferentially consid-
ered according to their P values. For comparison pur-
poses, we present a table of meta-analysis results for
all chromosomes for which at least one published
genome scan had a P value <0.01 (Table I).
30-51 For
chromosome regions where the MSP<0.001, we pre-
sent a “replication” MSP, where an MSP is calculated
for that region, excluding the most significant study.
Simulations show that the empirical P value of this
statistic is equivalent to the nominal P value, ie, a
replication MSP of 0.05 occurs ~1/20 times.The repli-
cation MSP statistic indicates whether the results of
the MSP for all the studies are primarily due to a sin-
gle significant study or whether other studies are also
contributing. For the analysis combining BP and SZ,
the most significant BP study and the most significant
SZ study are excluded from the replication MSP.
These meta-analysis results strongly suggest that a sta-
tistically promising susceptibility locus for BP and a sim-
ilarly promising susceptibility locus for SZ resides on
the 13q chromosomal region.If the evidence for BP and
SZ is combined, the data are consistent with the same
regions on two chromosomes (13 and 22) and leads to
the speculation that the same genes are conferring sus-
ceptibility to both illnesses.
19,53-55 The data on chromo-
some 22, which are suggestive in themselves, are of
increased interest because of deletions in the nearby
chromosomal region that cause velocardiofacial syn-
Clinical research
Chromosome BP SZ BP and SZ
Loc (cM) MSP Rep MSP Loc (cM) MSP Rep MSP Loc (cM) MSP Rep MSP
1 238 0.006 171 0.0009 0.4 171 0.01
2 116 7x10
-5 0.08
3 124 0.1
4 16 0.009 61 0.01 16 0.009
5 78 0.2 12 0.2 78 0.5
7 17 0.002 114 0.001 0.03 114 0.01
8 153 0.07 50 0.001 0.06 50 0.003
10 105 0.1 46 0.2 46 0.4
11 38 0.0005 76 0.02 38 0.03
12 64 0.1 109 0.01 109 0.06
13 79 7x10
-5 0.02 85 0.0008 0.1 85 4x10
-6 0.02
14 44 0.03
18 (p arm) 41 0.003 72 0.2 41 0.09
18 (q arm) 105 0.008
21 31 0.002
22 30 0.003 47 0.07 32 0.0005 0.01
X 40 0.3
Table I. Meta-analysis of linkage data in published whole-genome scans (as of October 2000). BP, bipolar manic depressive illness; SZ, schizo-
phrenia; Loc, location (in cM) of the locus with the most significant result from a single study in this region (location estimates are
obtained from the Marshfield map
52); MSP, multiple scan probability; Rep MSP, “replication” probability, which omits most significant
result of MSP (for the BP and SZ combined analysis, it omits two such results). Chromosomes are included if at least one study reported
P<0.01.67
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drome (VCFS), which includes a high frequency of BP
and SZ in the persons affected,as discussed below.
Additional positional strategies, such as linkage and
association in population isolates, are also being
employed in common disease inheritance,including psy-
chiatric illnesses,but for reasons of space they could not
be discussed here.
Phenotype redefinition
The concept of endophenotype refers to biological aspects of
illness that may have overlapping inheritance with an illness
within families, represent a component of the genetic sus-
ceptibility,and be more amenable to linkage and mutation
analysis than the related illness.
56 We may describe three
major classes of putative endophenotypes in SZ: atten-
tional,cognitive/communicative,and central nervous sys-
tem (CNS) structural. In BP, there has not been a corre-
sponding effort at endophenotype definition, although
therapeutic drug response,particularly to lithium,has been
investigated as a potential basis for genetic subtypes.
57
Eye-tracking findings 
The eye-tracking findings of Holzman in schizophrenic
families were the first attentional and neurophysiological
variables to stimulate the suggestion that there were
endophenotypes,and that separate genes might be found
for them.
58,59 Two major attention-related measures, the
P50 evoked potential and abnormal saccadic eye move-
ments,have been reported to be linked to discrete chro-
mosomal regions, on chromosomes 6 and 15.
60,61 Repli-
cations are awaited.A composite phenotype of the two
characteristics has been linked to chromosome 22.
62 The
attentional group of endophenotypes also includes the
P300 cortical evoked potential and other variables, on
which there are not yet molecular associations.
63,64
The cognitive group of variables 
There is a great deal of nonmolecular epidemiological
evidence for the cognitive group of variables,
65-69 ie,vari-
ables in which preschizophrenic children and children of
schizophrenic parents show deficits, and in which there
are deficits in relatives as well, include verbal working
memory, negative symptoms, communication distur-
bances (including speech and language impairments),
and “soft neurologic” and neurobehavioral measures.
There is evidence that the “deficit syndrome” in SZ is
familial as well.
70
Neuroanatomical variables
The third class,neuroanatomical variables,has had sev-
eral familial investigations,but none have reported asso-
ciated genetic markers.An interesting finding observed
repeatedly is increased ventricular volume in SZ
patients vs well siblings,with both groups having greater
volume than controls.
71-73
Age of onset
Does prepubertal onset of BP or SZ imply a genetically
distinct disease from older-onset illness? Work by Bad-
ner and Gershon
22 concluded that the cross-prevalence
of adult illness in families of child probands does not
support a separate disease entity,but that separate mol-
ecular and cytogenetic investigation of families with
childhood-onset has barely begun. Papolos et al
74
observed that BP illness associated with VCFS usually
has childhood onset,suggesting a separate entity;repli-
cation is awaited.
Among postpubertal onset BP and SZ (the vast major-
ity of cases), there is conflicting evidence on whether
early-onset is associated with increased morbid risk of
illness,
75-78 and there is no molecular or cytogenetic evi-
dence implying a separate inheritance in early- vs later-
onset postpubertal BP or SZ.
Alternative mechanisms of genetic 
transmission
Anticipation
Anticipation is present in genetic diseases when succes-
sive generations have earlier onset of illness, greater
severity, and/or greater likelihood of being affected.
Once the mechanism of expanding trinucleotide repeats
(TNRs) was discovered in fragile-X mental retardation,
and then in a succession of other neuropsychiatric dis-
eases, including Huntington’s disease and several spin-
ocerebellar atrophies, investigators began a scrutiny of
BP and SZ for anticipation and for expanding TNRs.
79
At present,observations consistent with anticipation are
being repeatedly reported,although there is some ques-
tion as to whether this is a birth-cohort effect or ascer-tainment artifact, as reviewed elsewhere.
80-83 There have
been some claims of expanding repeats associated with
major psychiatric illness, including an association with
childhood-onset SZ,
84 but nearly all of these repeats
have subsequently been shown to be common polymor-
phisms not associated with disease, as reviewed else-
where.
85 However,there remains some possibly disease-
associated TNRs that merit further investigation.
86
Aneuploidal events
VCFS is associated with deletions in a region on the q
arm of chromosome 22, including microdeletions, and
with psychiatric manifestations of BP and SZ.
85-87 Many
other aneuploidal events have been found in isolated
cases or families with BP or SZ,but the finding on chro-
mosome 22 is the most frequent.The region of reported
linkage to these disorders on the q arm of chromosome
22 is consistent with the finding of microdeletions.The
gene for catechol-O-methyltransferase (COMT) is
within the deletion region for VCFS. Modest evidence
for an association of COMT with SZ has been
reported,
90-92 but other studies do not find any evidence
for association in SZ
93,94 or in BP.
95
Sex-of-parent–specific transmission
BP has been reported to have excess maternal trans-
mission,
96,97 and some linkages appear to be specific to
paternal or maternal history.
96-98There has not been great
consistency in these observations,
99,100 but there are
enough repeated findings to consider mechanisms that
might be implicated.An associated mitochondrial vari-
ant has not appeared consistently.
101,102 Imprinting has
not been sufficiently investigated for comment.
Malaspina has presented data showing that sporadic
cases of SZ are associated with increased paternal age,
but not increased maternal age,implying that new muta-
tions may be playing a role.
103 Periodic catatonia,a form
of SZ, had a paternal parent-of-origin effect associated
with early onset in one series.
104
Candidate genes
In contrast to linkage, associations do not yet have an
agreed-upon criterion for genome-wide significance.
A plausible case can be made for each of a great many
genes that it is an a priori candidate, and that therefore
nominal significance of P<0.05 is adequate to provide
supportive evidence. However, as has been noted by
others,there are so many such genes that any one result
has to be looked at cautiously, even when it is highly
significant.
The neurodevelopmental hypothesis of SZ, supported
by the association of the illness with in utero infections
and obstetric complications, has generated genetic
hypotheses. Developmental genes known from lower
species are important in mammalian CNS development.
Reduced expression in SZ brain has been reported for
several of these,such as the genes encoding for Wnt-1,
105
reelin,
106 and neural cell adhesion molecule (NCAM),
107
although association of molecular variants of these genes
with SZ has not been demonstrated. NOTCH4, on the
other hand,has been reported to have a very significant
association with SZ,
108 and replication is awaited.
It had been suggested that Wolfram syndrome is associ-
ated with a large proportion of BP and SZ illness, but
now that the gene (wolframin) has been cloned, associ-
ation of BP with variants or markers of the gene has
not been observed.
109,110
Other candidate genes,based on altered neurotransmis-
sion hypotheses of BP and SZ,have been reviewed else-
where.
111-113
Conclusions
Eventually,the genetic epidemiology of BP and SZ will
include knowledge of genetic variants that increase
susceptibility to illness, as well as susceptibility to spe-
cific components of the illness and to side effects of
certain treatments.With such knowledge,an integrated
epidemiology becomes achievable, in which interac-
tion of these genetic susceptibilities with environmen-
tal events (such as exposure to infectious agents,drugs,
and various stressors) leads to useful predictions on
premorbid characteristics, onset of illness, course, and
response to treatment. The current knowledge on
genetic linkages, endophenotypes, and associations of
specific gene variants with illness and with side effects
of treatment may represent the beginnings of the
genetic component of a comprehensive epidemiology
of these mental disorders. ❑
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Incorporación de información molecular y
redefinición del fenotipo: nuevas
aproximaciones a la epidemiología
genética de la enfermedad bipolar
maníaco-depresiva y de la esquizofrenia
Se han realizado avances significativos en la
identificación de componentes genéticos espe-
cíficos de la enfermedad bipolar maníaco-
depresiva (BP) y de la esquizofrenia (EQZ) a
pesar de su compleja herencia. El meta-análisis
de todos los mapeos de enlaces del genoma
completo publicados revela una fuerte base
para genes enfermos en regiones de algunos
cromosomas. En dos de estas regiones, en el
brazo largo del cromosoma 13 y en el brazo
largo el cromosoma 22, los estudios combina-
dos de BP y EQZ son consistentes con un locus
de susceptibilidad común para los dos trastor-
nos. Esto proporciona alguna credibilidad a la
hipótesis de cierta predisposición genética com-
partida para BP y EQZ. Otros enlaces están sus-
tentados por múltiples estudios de regiones
cromosómicas específicas, más notablemente
dos regiones en el cromosoma 6 en la EQZ. El
síndrome velocardiofacial está asociado con
supresiones muy cercanas a la región de enlace
en el cromosoma 22 y con manifestaciones psi-
quiátricas tanto de BP como de EQZ. Endofeno-
tipos de EQZ, que previamente demostraron ser
heredados, al menos en un estudio se ha
encontrado que tienen ligazón cromosómica.
Estos incluyen anormalidades del seguimiento
ocular, el cual está ligado al brazo corto del cro-
mosoma 6 y anormalidades del potencial evo-
cado cortical P50 ligado al cromosoma 15. Se
han asociado variantes en genes específicos con
la susceptibilidad para la enfermedad, y otros
genes se han vinculado con susceptibilidad a los
efectos colaterales del tratamiento farmacoló-
gico. Estos hallazgos genéticos pueden ser
parte, eventualmente, de una integración
genética, ambiental y de un factor epidemioló-
gico interactivo en las principales enfermeda-
des mentales.
Prise en compte des données moléculaires
et redéfinition du phénotype : avancées
dans le domaine de l’épidémiologie
génétique de la maladie bipolaire
maniacodépressive et de la schizophrénie 
Des avancées très importantes ont été réalisées
dans l’identification des composants génétiques
spécifiques porteurs de la psychose maniacodé-
pressive (PMD) et de la schizophrénie (SZ) malgré
l’hérédité complexe de ces deux maladies. Une
métaanalyse de la carte des liaisons génétiques
publiées sur l’ensemble du génome révèle un
consensus général sur l’atteinte des gènes dans
plusieurs régions chromosomiques. Dans deux de
ces régions, sur le bras long du chromosome 13
et celui du chromosome 22, les résultats des
études combinées sur la PMD et la SZ sont
concordants et incriminent un gène commun de
susceptibilité pour les deux maladies. L’hypothè-
se de prédispositions génétiques communes à la
PMD et à la SZ se trouve donc confortée.
D’autres régions chromosomiques spécifiques,
surtout deux régions sur le chromosome 6 dans
la SZ, ont fait l’objet de multiples études qui ont
mis en évidence d’autres liaisons. Le syndrome
vélo-cardio-facial est associé à des délétions très
proches du groupe de liaison sur le chromosome
22 et à des manifestations psychiatriques iden-
tiques à celles de la PMD et à la SZ. Une étude au
moins a mis en évidence des liaisons chromoso-
miques avec les endophénotypes de la SZ,
connus comme étant héréditaires. Ces liaisons
concernent les anomalies de la poursuite oculai-
re liées au bras court du chromosome 6 et une
anomalie du potentiel évoqué cortical P50 liée
au chromosome 15. Des variantes de gènes spé-
cifiques ont été associées à une prédisposition à
la maladie et d’autres gènes à une susceptibilité
aux effets secondaires du traitement. Ces don-
nées génétiques pourraient un jour trouver leur
place dans le cadre d'une définition épidémiolo-
gique des principales maladies psychiatriques
intégrant les aspects génétiques et environne-
mentaux ainsi que les facteurs interactifs.Clinical research
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